Alaunos Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Adcock Ingram Holdings ZAR 4.42B 268.95M 2024-06
Alaunos Therapeutics USD 759K 391K 2024-12
Amgen USD 6.78B 401M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Baxter International USD 3.19B 644M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Bioline Rx USD 10.33M 836K 2024-09
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Celltrion KRW 674.25B 128.01B 2024-09
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Ecofibre AUD 12.31M 44.07M 2024-06
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
J&J USD 8.26B 10.37B 2025-03
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Merck USD 9.66B 1.67B 2025-03
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Pharma Mar EUR 41.94M 1.53M 2025-03
PTC Therapeutics USD 275.66M 24.36M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sartorius EUR 745.6M 21.2M 2025-03
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Tilray USD 253.17M 16.55M 2024-11
Zz Pientze Pharmaceu 1.96B 275.44K 2025-03



Alaunos Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.